BDSX — Biodesix Inc · rev $52.4M

Biodesix Inc (BDSX) is a diagnostics & research company listed on NASDAQ.

Latest reported BDSX revenue for 2026-06-30 was $52.4M. Net income was -$15.1M. BDSX currently screens at market cap $157.6M.

Use this BDSX page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the BDSX quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the BDSX SEC filings page. Lician reads the product cache first so this HTML stays unique to Biodesix Inc even when a live quote feed is slow.